FIGURE

Figure 6

ID

ZDB-FIG-240226-178

Publication

Wu et al., 2024 - Hypolipidemic and Antithrombotic Effect of 6'-O-Caffeoylarbutin from Vaccinium dunalianum Based on Zebrafish Model, Network Pharmacology, and Molecular Docking

Other Figures

All Figure Page

Back to All Figure Page

Figure 6

The molecular docking results of CA with core hyperlipidemia and thrombosis targets. (A) CA with PRKACA (PDB ID: 5M6Y); (B) CA with ESR1 (PDB ID: 7NFB); (C) CA with HNF4A (PDB ID: 8C1L); (D) CA with HSP90AA1 (PDB ID: 6TN5); (E) CA with IL2 (PDB ID: 7M2G); (F) CA with MMP9 (PDB ID: 6ESM); (G) CA with MMP2 (PDB ID: 7XJO); (H) CA with APP (PDB ID: 2FMA); (I) CA with PRKCA (PDB ID: 2GZV); (J) CA with RELA (PDB ID: 8ONV).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Molecules